| Bristol-Myers Squibb SA - Opdivo 120 mg/12 ml, Konzentrat zur Herstellung einer Infusionslösung | | 65660 | | 04 | | Opdivo 120 mg/12 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FF01 | | | | 27.10.2022 | | |
| | Composition | | nivolumabum 120 mg, natrii citras dihydricus, natrii chloridum, mannitolum, acidum penteticum, polysorbatum 80, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 12 ml corresp. natrium 30 mg. | | Packungsbestandteile | | Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Nivolumabum | 120mg / 12ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Acidum Penteticum | | Mannitol | | Sodium Chloride | | Natrii Citras Dihydricus | | Sodium Hydroxide | | Polysorbatum 80 |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | | PR | PR | A | | Yes |
|
|
